MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
NPSA: Commitment to 'Australia’s critical infrastructure for health'
November 21, 2019 - - Latest News -
Wholesaler move to go it alone is just one key difference
November 21, 2019 - - Latest News -
Greg Hunt frustrated over refusal to treat with CAR-T
November 21, 2019 - - Latest News -
Australian company Noxopharm updates on pipeline
November 21, 2019 - - Latest News -
Minister doubles-down on pharmacy tribunal
November 20, 2019 - - Latest News -
December extensions for two cancer medicines
November 20, 2019 - - Latest News -
Companies, clinicians and patients welcome cancer listings
November 20, 2019 - - Latest News